Skip to main content
Back
Watch Compare

Aspira Women's Health Inc.

Data quality: 100%
AWHL
OTC Manufacturing Chemicals
$0.30
▲ $0.02 (7.14%)
Mkt Cap: 13.05 M
Price
$0.30
Mkt Cap
13.05 M
Day Range
$0.30 — $0.31
52-Week Range
$0.02 — $0.71
Volume
6,886
Open $0.30
50D / 200D Avg
$0.37
18.35% below
50D / 200D Avg
$0.39
23.84% below

Quick Summary

Key Takeaways

Revenue declined -52.63% annually over 5 years
Negative free cash flow of -7.05 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 38.80%
Capital efficient — spends only 4.66% of revenue on capex

Growth

Revenue Growth (5Y)
-52.63%
Below sector avg (1.82%)
Revenue (1Y)-91.43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-265.95%
Net Margin-3725.95%
Op. Margin-2307.00%

Safety

Debt / Equity
N/A
Current Ratio1.39
Interest Coverage-193.00

Valuation

PE (TTM)
-1.02
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.0 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -3726.0 -41.5
Rev Growth 5Y % -52.6 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -91.43% Revenue Growth (3Y) -80.64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -52.63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 343,000.0 Net Income (TTM) -12.78 M
ROE N/A ROA -208.99%
Gross Margin 1724.49% Operating Margin -2307.00%
Net Margin -3725.95% Free Cash Flow (TTM) -7.05 M
ROIC -265.95% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.39
Interest Coverage -193.00 Asset Turnover 0.06
Working Capital 1.63 M Tangible Book Value -4.69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.02 Forward P/E N/A
P/B Ratio N/A P/S Ratio 38.05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -53.98%
Market Cap 13.05 M Enterprise Value 11.19 M
Per Share
EPS (Diluted TTM) -0.37 Revenue / Share 0.01
FCF / Share -0.16 OCF / Share -0.16
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4.66% FCF Conversion 55.13%
SBC-Adj. FCF -7.56 M Growth Momentum -38.80

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 343,000.0 4.00 M 9.15 M 8.18 M 6.81 M
Net Income -12.78 M -13.09 M -16.69 M -27.17 M -31.66 M
EPS (Diluted) -0.37 -0.93 -1.81 -0.23 -0.28
Gross Profit 5.92 M 5.48 M 5.26 M 4.32 M 3.06 M
Operating Income -7.91 M -16.28 M -18.85 M -32.77 M -32.60 M
EBITDA — — — — —
R&D Expenses 2.88 M 3.27 M 4.04 M 5.95 M 5.31 M
SG&A Expenses — — — — —
D&A — — 199,000.0 264,000.0 302,000.0
Interest Expense -41,000.0 -33,000.0 48,000.0 17,000.0 -48,000.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.46 M 5.49 M 6.26 M 17.37 M 41.08 M
Total Liabilities 12.39 M 8.05 M 8.63 M 10.64 M 10.91 M
Shareholders' Equity -6.93 M -2.56 M -2.37 M 6.73 M 30.17 M
Total Debt 1.77 M 2.12 M 2.27 M 3.48 M 3.70 M
Cash & Equivalents 1.76 M 1.77 M 2.60 M 13.31 M 37.18 M
Current Assets 4.06 M 4.18 M 5.28 M 16.31 M 40.01 M
Current Liabilities 3.47 M 5.47 M 5.12 M 5.78 M 7.84 M